These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 22356194)
1. Targeting strategies for Human immunodeficiency virus: a combinatorial approach. Saxena SK; Gupta A; Bhagyashree K; Saxena R; Arora N; Banerjee AK; Tripathi AK; Chandrasekar MJ; Gandhi N; Nair MP Mini Rev Med Chem; 2012 Mar; 12(3):236-54. PubMed ID: 22356194 [TBL] [Abstract][Full Text] [Related]
2. Entry inhibitors directed towards glycoprotein gp120: an overview on a promising target for HIV-1 therapy. Flores A; Quesada E Curr Med Chem; 2013 Feb; 20(6):751-71. PubMed ID: 23278399 [TBL] [Abstract][Full Text] [Related]
3. A Review on Quinoline Derived Scaffolds as Anti-HIV Agents. Chokkar N; Kalra S; Chauhan M; Kumar R Mini Rev Med Chem; 2019; 19(6):510-526. PubMed ID: 30338737 [TBL] [Abstract][Full Text] [Related]
5. [The HIV replication cycle. Established therapeutic targets and potential targets]. Alcamí J Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 12():3-10. PubMed ID: 19572419 [TBL] [Abstract][Full Text] [Related]
6. Current and Emerging Drug Targets for Human Immunodeficiency Virus. Waheed AA; Tachedjian G Curr Top Med Chem; 2016; 16(10):1072-3. PubMed ID: 26381413 [No Abstract] [Full Text] [Related]
7. Targeting HIV attachment and entry for therapy. Strizki J Adv Pharmacol; 2008; 56():93-120. PubMed ID: 18086410 [No Abstract] [Full Text] [Related]
8. Target Molecules and Delivery Vehicles for Anti-HIV Drugs In vitro and In vivo. Bolhassani A Curr Pharm Des; 2018; 24(29):3393-3401. PubMed ID: 29886823 [TBL] [Abstract][Full Text] [Related]
9. Maturation inhibitors: a new therapeutic class targets the virus structure. Salzwedel K; Martin DE; Sakalian M AIDS Rev; 2007; 9(3):162-72. PubMed ID: 17982941 [TBL] [Abstract][Full Text] [Related]
11. Antiretroviral drug development for HIV: challenges for the future. Boone LR; Koszalka GW Curr Opin Investig Drugs; 2010 Aug; 11(8):863-67. PubMed ID: 21072979 [TBL] [Abstract][Full Text] [Related]
12. Heterobiaryl human immunodeficiency virus entry inhibitors. Lu RJ; Tucker JA; Pickens J; Ma YA; Zinevitch T; Kirichenko O; Konoplev V; Kuznetsova S; Sviridov S; Brahmachary E; Khasanov A; Mikel C; Yang Y; Liu C; Wang J; Freel S; Fisher S; Sullivan A; Zhou J; Stanfield-Oakley S; Baker B; Sailstad J; Greenberg M; Bolognesi D; Bray B; Koszalka B; Jeffs P; Jeffries C; Chucholowski A; Sexton C J Med Chem; 2009 Jul; 52(14):4481-7. PubMed ID: 19534463 [TBL] [Abstract][Full Text] [Related]
13. The challenge of finding a cure for HIV infection. Richman DD; Margolis DM; Delaney M; Greene WC; Hazuda D; Pomerantz RJ Science; 2009 Mar; 323(5919):1304-7. PubMed ID: 19265012 [TBL] [Abstract][Full Text] [Related]
14. In search of a treatment for HIV--current therapies and the role of non-nucleoside reverse transcriptase inhibitors (NNRTIs). Reynolds C; de Koning CB; Pelly SC; van Otterlo WA; Bode ML Chem Soc Rev; 2012 Jul; 41(13):4657-70. PubMed ID: 22618809 [TBL] [Abstract][Full Text] [Related]
15. Chasing HIV from its hiding place. Erdmann J Chem Biol; 2010 Aug; 17(8):787-8. PubMed ID: 20797604 [No Abstract] [Full Text] [Related]
16. How to win the HIV-1 drug resistance hurdle race: running faster or jumping higher? Garbelli A; Riva V; Crespan E; Maga G Biochem J; 2017 Apr; 474(10):1559-1577. PubMed ID: 28446620 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of human immunodeficiency virus type 1 (HIV-1) nuclear import via Vpr-Importin alpha interactions as a novel HIV-1 therapy. Suzuki T; Yamamoto N; Nonaka M; Hashimoto Y; Matsuda G; Takeshima SN; Matsuyama M; Igarashi T; Miura T; Tanaka R; Kato S; Aida Y Biochem Biophys Res Commun; 2009 Mar; 380(4):838-43. PubMed ID: 19338763 [TBL] [Abstract][Full Text] [Related]
18. Targets for inhibition of HIV replication: entry, enzyme action, release and maturation. Sierra-Aragón S; Walter H Intervirology; 2012; 55(2):84-97. PubMed ID: 22286875 [TBL] [Abstract][Full Text] [Related]
19. Targeting HIV: antiretroviral therapy and development of drug resistance. Menéndez-Arias L Trends Pharmacol Sci; 2002 Aug; 23(8):381-8. PubMed ID: 12377580 [TBL] [Abstract][Full Text] [Related]
20. Current problems and the future of antiretroviral drug trials. Lange JM Science; 1997 Apr; 276(5312):548-50. PubMed ID: 9148417 [No Abstract] [Full Text] [Related] [Next] [New Search]